...
首页> 外文期刊>Genomics & Informatics >Analysis of Gene Expression in Cyclooxygenase-2-Overexpressed Human Osteosarcoma Cell Lines
【24h】

Analysis of Gene Expression in Cyclooxygenase-2-Overexpressed Human Osteosarcoma Cell Lines

机译:环氧合酶-2过表达的人骨肉瘤细胞系中基因表达的分析

获取原文
           

摘要

Osteosarcoma is the most common primary bone tumor, generally affecting young people. While the etiology of osteosarcoma has been largely unknown, recent studies have suggested that cyclooxygenase-2 (COX-2) plays a critical role in the proliferation, migration, and invasion of osteosarcoma cells. To understand the mechanism of action of COX-2 in the pathogenesis of osteosarcoma, we compared gene expression patterns between three stable COX-2-overexpressing cell lines and three control cell lines derived from U2OS human osteosarcoma cells. The data showed that 56 genes were upregulated, whereas 20 genes were downregulated, in COX-2-overexpressed cell lines, with an average fold-change > 1.5. Among the upregulated genes, COL1A1, COL5A2, FBN1, HOXD10, RUNX2, and TRAPPC2are involved in bone and skeletal system development, while DDR2, RAC2, RUNX2, and TSPAN31are involved in the positive regulation of cell proliferation. Among the downregulated genes, HIST1H1D, HIST1H2AI, HIST1H3H, and HIST1H4C are involved in nucleosome assembly and DNA packaging. These results may provide useful information to elucidate the molecular mechanism of the COX-2-mediated malignant phenotype in osteosarcoma.
机译:骨肉瘤是最常见的原发性骨肿瘤,通常会影响年轻人。尽管骨肉瘤的病因学尚不清楚,但最近的研究表明,环氧合酶2(COX-2)在骨肉瘤细胞的增殖,迁移和侵袭中起着至关重要的作用。为了了解COX-2在骨肉瘤发病机理中的作用机理,我们比较了三种稳定的COX-2过表达细胞系和三种源自U2OS人骨肉瘤细胞的对照细胞系之间的基因表达模式。数据显示,在COX-2过表达的细胞系中,有56个基因上调,而有20个基因下调,平均倍数变化> 1.5。在上调的基因中,COL1A1,COL5A2,FBN1,HOXD10,RUNX2和TRAPPC2参与骨骼和骨骼系统的发育,而DDR2,RAC2,RUNX2和TSPAN31参与细胞增殖的正向调控。在下调的基因中,HIST1H1D,HIST1H2AI,HIST1H3H和HIST1H4C参与核小体组装和DNA包装。这些结果可能为阐明骨肉瘤中COX-2介导的恶性表型的分子机制提供有用的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号